Technical Analysis for TNFA - TNF Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 1.22 -0.81% -0.01
TNFA closed up 7.42 percent on Wednesday, November 20, 2024, on 1.72 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down

Date Alert Name Type % Chg
Wide Bands Range Expansion -0.81%
Oversold Stochastic Weakness -0.81%
New 52 Week Closing Low Bearish 6.55%
New 52 Week Low Weakness 6.55%
Wide Bands Range Expansion 6.55%
Oversold Stochastic Weakness 6.55%
Stochastic Buy Signal Bullish 0.33%
Inside Day Range Contraction 0.33%
Wide Bands Range Expansion 0.33%
Oversold Stochastic Weakness 0.33%

   Recent Intraday Alerts

Alert Time
Up 1% about 1 hour ago
Down 3% about 3 hours ago
Down 2 % about 3 hours ago
Down 1% about 3 hours ago
Up 2% 1 day ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

TNF Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. It focuses on developing and commercializing the MyMD-1 and SUPERA-CBD therapeutic platforms. MyMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune diseases. Supera-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in Baltimore, MD.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Pain Autoimmune Disease Disorders Chronic Pain Depression Epilepsy Analgesics Drug Products Cannabidiol Neurodegenerative Disease Sjögren Syndrome Anticonvulsants

Is TNFA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.16
52 Week Low 1.13
Average Volume 37,488
200-Day Moving Average 0.00
50-Day Moving Average 1.46
20-Day Moving Average 1.38
10-Day Moving Average 1.27
Average True Range 0.13
RSI (14) 40.83
ADX 23.89
+DI 12.16
-DI 23.02
Chandelier Exit (Long, 3 ATRs) 1.40
Chandelier Exit (Short, 3 ATRs) 1.53
Upper Bollinger Bands 1.73
Lower Bollinger Band 1.03
Percent B (%b) 0.29
BandWidth 51.18
MACD Line -0.10
MACD Signal Line -0.08
MACD Histogram -0.0159
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.41
Resistance 3 (R3) 1.40 1.33 1.38
Resistance 2 (R2) 1.33 1.28 1.34 1.37
Resistance 1 (R1) 1.28 1.26 1.31 1.29 1.36
Pivot Point 1.21 1.21 1.22 1.22 1.21
Support 1 (S1) 1.16 1.16 1.19 1.17 1.10
Support 2 (S2) 1.09 1.14 1.10 1.09
Support 3 (S3) 1.04 1.09 1.08
Support 4 (S4) 1.05